학술논문

Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study
Document Type
Article
Source
In: Cephalalgia. (Cephalalgia, November 2021, 41(13):1285-1297)
Subject
Language
English
ISSN
14682982
03331024